These effects are blunted by NAC, indicating that the generation of ROS through the KRAS–AKT axis is necessary to mediate C1 cytotoxicity, corroborating the feasibility of a ROS-based anticancer strategy to target KRAS-driven tumours. Here, KRAS is linked to neoplasm.